146 related articles for article (PubMed ID: 35110458)
1. Immunohistochemical features of canine ovarian papillary adenocarcinoma and utility of cell block technique for detecting neoplastic cells in body cavity effusions.
Kita C; Chambers JK; Tanabe M; Irie M; Yamasaki H; Uchida K
J Vet Med Sci; 2022 Mar; 84(3):406-413. PubMed ID: 35110458
[TBL] [Abstract][Full Text] [Related]
2. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
[No Abstract] [Full Text] [Related]
3. The cell tube block technique and an immunohistochemistry panel including Wilms tumor 1 to assist in diagnosing cavitary effusions in dogs and cats.
Marcos R; Marrinhas C; Malhão F; Canadas A; Santos M; Caniatti M
Vet Clin Pathol; 2019 Mar; 48(1):50-60. PubMed ID: 30865320
[TBL] [Abstract][Full Text] [Related]
4. Canine ovarian tumors: an immunohistochemical study with HBME-1 antibody.
Banco B; Antuofermo E; Borzacchiello G; Cossu-Rocca P; Grieco V
J Vet Diagn Invest; 2011 Sep; 23(5):977-81. PubMed ID: 21908358
[TBL] [Abstract][Full Text] [Related]
5. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions.
Chen CJ; Chang SC; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Sep; 54(3):149-55. PubMed ID: 7954054
[TBL] [Abstract][Full Text] [Related]
6. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
Lee BH; Hecht JL; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
[TBL] [Abstract][Full Text] [Related]
7. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
Conner JR; Cibas ES; Hornick JL; Qian X
Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
[TBL] [Abstract][Full Text] [Related]
8. Utility of GATA-3 in the work-Up of breast adenocarcinoma and its differential diagnosis in serous effusions:: A Cell-Block Microarray Study.
El Hag MI; Ha J; Farag R; El Hag AM; Michael CW
Diagn Cytopathol; 2016 Sep; 44(9):731-6. PubMed ID: 27338760
[TBL] [Abstract][Full Text] [Related]
9. IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.
Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
Hum Pathol; 2010 May; 41(5):745-50. PubMed ID: 20060157
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
Afify A; Zhou H; Howell L; Paulino AF
Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
[TBL] [Abstract][Full Text] [Related]
11. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?
Lyons-Boudreaux V; Mody DR; Zhai J; Coffey D
Arch Pathol Lab Med; 2008 Jan; 132(1):23-8. PubMed ID: 18181669
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical diagnosis of canine ovarian epithelial and granulosa cell tumors.
Riccardi E; Grieco V; Verganti S; Finazzi M
J Vet Diagn Invest; 2007 Jul; 19(4):431-5. PubMed ID: 17609358
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations.
Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
Diagn Cytopathol; 2011 Jun; 39(6):395-401. PubMed ID: 21574259
[TBL] [Abstract][Full Text] [Related]
14. Malignant effusion of chromophobe renal-cell carcinoma: cytological and immunohistochemical findings.
Teresa P; Grazia ZM; Doriana M; Irene P; Michele S
Diagn Cytopathol; 2012 Jan; 40(1):56-61. PubMed ID: 22180239
[TBL] [Abstract][Full Text] [Related]
15. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
Bassarova AV; Nesland JM; Davidson B
Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
[TBL] [Abstract][Full Text] [Related]
16. Mucinous Pleural Effusion in a Dog with a Pulmonary Adenocarcinoma and Carcinomatosis.
Tropf M; Sellon R; Paulson K; Nelson D
J Am Anim Hosp Assoc; 2015; 51(5):311-4. PubMed ID: 26355581
[TBL] [Abstract][Full Text] [Related]
17. Growth of adenocarcinoma from canine pleural fluid on aerobic bacterial culture.
Dusick AF; Bach JF; Liao PT; Hartmann FA
J Vet Diagn Invest; 2020 Jan; 32(1):156-158. PubMed ID: 31744399
[TBL] [Abstract][Full Text] [Related]
18. Cytologic features and diagnostic accuracy of analysis of effusions for detection of ovarian carcinoma in dogs.
Bertazzolo W; Bonfanti U; Mazzotti S; Gelain ME
Vet Clin Pathol; 2012 Mar; 41(1):127-32. PubMed ID: 22250601
[TBL] [Abstract][Full Text] [Related]
19. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
[TBL] [Abstract][Full Text] [Related]
20. LI-cadherin and CDX2: Useful Markers in Metastatic Gastrointestinal Adenocarcinoma Cells in Serous Cavity Effusion.
Ma H; Yu J; Tang J
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):e75-e80. PubMed ID: 30095466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
